tiprankstipranks
China SXT Pharmaceuticals Inc (DE:2RY2)
FRANKFURT:2RY2
Germany Market
2RY2
China SXT Pharmaceuticals
RESEARCH TOOLSreports

China SXT Pharmaceuticals (2RY2) Ratios

0 Followers

China SXT Pharmaceuticals Ratios

DE:2RY2's free cash flow for Q4 2026 was $0.70. For the 2026 fiscal year, DE:2RY2's free cash flow was decreased by $ and operating cash flow was $-0.65. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 7.93 7.93 3.54 1.60 1.35
Quick Ratio
 7.25 7.25 3.40 1.51 1.31
Cash Ratio
 6.48 6.48 3.01 1.36 1.20
Solvency Ratio
 -1.43 -1.20 -0.52 -0.31 -0.38
Operating Cash Flow Ratio
 -1.41 -0.92 -0.39 -0.22 >-0.01
Short-Term Operating Cash Flow Coverage
 -14.51 -9.49 -3.30 -0.84 -0.02
Net Current Asset Value
$ 29.46M$ 29.46M$ 15.07M$ 5.04M$ 4.66M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.05 0.11 0.13
Debt-to-Equity Ratio
 0.04 0.04 0.06 0.19 0.26
Debt-to-Capital Ratio
 0.04 0.04 0.06 0.16 0.20
Long-Term Debt-to-Capital Ratio
 0.02 0.02 <0.01 <0.01 <0.01
Financial Leverage Ratio
 1.17 1.17 1.40 1.66 2.01
Debt Service Coverage Ratio
 -9.51 -14.63 -1.89 -0.83 -1.37
Interest Coverage Ratio
 -27.39 -113.13 -4.14 -4.62 -11.76
Debt to Market Cap
 0.90 0.01 <0.01 0.21 0.23
Interest Debt Per Share
 2.45 1.74 4.04 3.68 15.86
Net Debt to EBITDA
 3.23 3.88 6.65 4.01 2.61
Profitability Margins
Gross Profit Margin
44.37%17.09%21.11%28.73%21.62%
EBIT Margin
-336.53%-664.06%-152.53%-132.45%-276.82%
EBITDA Margin
-329.79%-650.71%-147.80%-121.91%-264.13%
Operating Profit Margin
-336.53%-664.06%-153.97%-130.42%-284.40%
Pretax Profit Margin
-344.88%-566.29%-189.77%-160.67%-301.00%
Net Profit Margin
-290.71%-578.49%-189.77%-160.67%-301.00%
Continuous Operations Profit Margin
-290.71%-578.49%-189.77%-160.67%-301.00%
Net Income Per EBT
84.29%102.15%100.00%100.00%100.00%
EBT Per EBIT
102.48%85.28%123.25%123.19%105.84%
Return on Assets (ROA)
-21.22%-17.85%-15.25%-13.40%-20.08%
Return on Equity (ROE)
-31.02%-20.89%-21.40%-22.24%-40.40%
Return on Capital Employed (ROCE)
-28.07%-23.43%-17.13%-17.68%-37.24%
Return on Invested Capital (ROIC)
-23.34%-23.11%-16.32%-15.17%-30.40%
Return on Tangible Assets
-21.22%-17.86%-15.26%-13.41%-20.10%
Earnings Yield
-564.49%-6.79%-0.03%-26.90%-39.19%
Efficiency Ratios
Receivables Turnover
 0.78 0.33 0.92 1.43 1.47
Payables Turnover
 2.84 1.79 1.19 1.07 1.12
Inventory Turnover
 0.48 0.30 1.66 1.70 2.91
Fixed Asset Turnover
 10.63 4.50 4.90 3.42 1.55
Asset Turnover
 0.07 0.03 0.08 0.08 0.07
Working Capital Turnover Ratio
 0.08 0.05 0.17 0.37 0.38
Cash Conversion Cycle
 1.10K 2.11K 310.63 130.09 48.96
Days of Sales Outstanding
 465.13 1.10K 398.39 254.83 248.91
Days of Inventory Outstanding
 764.72 1.21K 220.05 215.03 125.47
Days of Payables Outstanding
 128.73 204.24 307.82 339.77 325.43
Operating Cycle
 1.23K 2.31K 618.44 469.86 374.38
Cash Flow Ratios
Operating Cash Flow Per Share
 -10.48 -5.91 -5.81 -2.22 -0.30
Free Cash Flow Per Share
 -8.79 -5.91 -5.81 -2.23 -0.57
CapEx Per Share
 1.69 <0.01 <0.01 <0.01 0.26
Free Cash Flow to Operating Cash Flow
 0.84 1.00 1.00 1.00 1.88
Dividend Paid and CapEx Coverage Ratio
 -6.21 -1.00M -1.16K -272.98 -1.14
Capital Expenditure Coverage Ratio
 -6.21 -1.00M -1.16K -272.98 -1.14
Operating Cash Flow Coverage Ratio
 -5.48 -3.58 -2.38 -0.73 -0.02
Operating Cash Flow to Sales Ratio
 -2.42 -3.75 -1.35 -1.00 -0.04
Free Cash Flow Yield
-432.49%-4.40%-0.02%-16.80%-1.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.26 -14.72 -3.66K -3.72 -2.55
Price-to-Sales (P/S) Ratio
 0.47 85.16 6.95K 5.97 7.68
Price-to-Book (P/B) Ratio
 0.04 3.07 783.22 0.83 1.03
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.23 -22.74 -5.15K -5.95 -99.99
Price-to-Operating Cash Flow Ratio
 -0.21 -22.74 -5.16K -5.97 -187.51
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -1.27 -28.34 0.04 0.03
Price-to-Fair Value
 0.04 3.07 783.22 0.83 1.03
Enterprise Value Multiple
 3.09 -9.21 -4.69K -0.89 -0.29
Enterprise Value
 -25.86M 64.29M 12.08B 2.10M 1.53M
EV to EBITDA
 3.09 -9.21 -4.69K -0.89 -0.29
EV to Sales
 -10.20 59.94 6.94K 1.09 0.78
EV to Free Cash Flow
 5.02 -16.00 -5.14K -1.08 -10.11
EV to Operating Cash Flow
 4.21 -16.00 -5.15K -1.09 -18.96
Tangible Book Value Per Share
 50.70 43.70 38.20 16.04 54.92
Shareholders’ Equity Per Share
 50.71 43.71 38.22 16.06 55.03
Tax and Other Ratios
Effective Tax Rate
 0.16 -0.02 0.00 0.00 0.00
Revenue Per Share
 4.33 1.58 4.31 2.22 7.39
Net Income Per Share
 -12.59 -9.13 -8.18 -3.57 -22.23
Tax Burden
 0.84 1.02 1.00 1.00 1.00
Interest Burden
 1.02 0.85 1.24 1.21 1.09
Research & Development to Revenue
 0.00 0.17 0.11 0.10 0.00
SG&A to Revenue
 3.71 6.64 1.75 1.37 2.86
Stock-Based Compensation to Revenue
 -0.07 0.00 0.00 0.18 0.28
Income Quality
 0.71 0.65 0.71 0.62 0.01
Currency in USD